PetMed Express d/b/a 1-800-PetMeds to Announce Its Third Quarter Financial Results on January 19, 2021
January 12 2021 - 8:00AM
PetMed Express, Inc. (NASDAQ: PETS) will announce its financial
results for the quarter ended December 31, 2020 on Tuesday, January
19, 2021 at 8:00 A.M. Eastern Time, then at 8:30 A.M. Eastern Time,
Menderes Akdag, the Company’s Chief Executive Officer and
President, will host a conference call to review the financial
results.
To access the call, which is open to the public,
please dial (888) 455-1758 (toll free) or (203) 827-7025, ten
minutes prior to the scheduled start time. Callers will be required
to supply PETMEDS as the passcode, and will be placed on hold with
music until the call begins.
For those unable to participate in the live
event, the call will be available for replay from 10:00 A.M.
Eastern Time on January 19, 2021 until February 2, 2021 at 11:59
P.M. Eastern Time. To access the replay, call (888) 676-2680 (toll
free) or (402) 220-6446, and enter passcode 5500.
Founded in 1996, PetMed Express is America’s
Largest and Most Trusted Pet Pharmacy, delivering prescription and
non-prescription pet medications and other health products for
dogs, cats, and horses at competitive prices direct to the consumer
through its 1-800-PetMeds toll free number and on the Internet
through its website at www.1800petmeds.com.
This press release may contain “forward-looking”
statements, as defined in the Private Securities Litigation Reform
Act of 1995 or by the Securities and Exchange Commission, that
involve a number of risks and uncertainties, including the
Company’s ability to meet the objectives included in its business
plan. Important factors that could cause results to differ
materially from those indicated by such “forward-looking”
statements are set forth in Management’s Discussion and Analysis of
Financial Condition and Results of Operations in the PetMed Express
Annual Report on Form 10-K for the year ended March 31, 2020. The
Company’s future results may also be impacted by other risk factors
listed from time to time in its SEC filings, including, but not
limited to, the Company's Form 10-Q and its Annual Report on Form
10-K.
For investment relations contact PetMed Express,
Inc., Bruce S. Rosenbloom, CFO, 561-526-4444.
PetMed Express (NASDAQ:PETS)
Historical Stock Chart
From Jun 2024 to Jul 2024
PetMed Express (NASDAQ:PETS)
Historical Stock Chart
From Jul 2023 to Jul 2024